|
'Big
will become bigger'
3i which was in news along with Dr Reddy's over betapharm,
has forayed into the country as 3i India Private Limited.
Mahesh Chhabria, Director of 3i India, talks to Nandini Patwardhan.
Not
bowled till it's bowled
Arshiya Khan maps out the turning tides during the IPO voyage
of Ind-Swift Laboratories.
Brand
of trust
Gauri Chaudhari talks about the essentials in building a strong
brand name.
Biotech—hope,
hype or reality?
The biotechnology sector provides the Indian industry a galore
of opportunities which are appealing and attractive. What
are the pros and cons of this sunrise sector? Sushmi Dey finds
out in conversation with industry experts.
'RFID
lends itself into a lot of business applications'
RFID seems an answer to the counterfeiting stricken pharma
industry. Arun Ramachandran, Head of Pre-sales and Professional
services of Sybase talks to Katya Naidu on the significance
of this technology.
|
